GlycoMimetics (GLYC) Short Interest Ratio & Short Volume $0.26 +0.01 (+3.09%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends GlycoMimetics Short Interest DataGlycoMimetics (GLYC) has a short interest of 2.17 million shares. This marks a -2.69% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 572,390 shares to cover all short positions.Current Short Interest2,170,000 sharesPrevious Short Interest2,230,000 sharesChange Vs. Previous Month-2.69%Dollar Volume Sold Short$540,330.00Short Interest Ratio0.1 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares64,484,000 sharesPercentage of Shares Shorted3.37%Today's Trading Volume225,625 sharesAverage Trading Volume572,390 sharesToday's Volume Vs. Average39% Short Selling GlycoMimetics? Sign up to receive the latest short interest report for GlycoMimetics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGLYC Short Interest Over TimeGLYC Days to Cover Over TimeGLYC Percentage of Float Shorted Over Time GlycoMimetics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/20242,170,000 shares $540,330.00 -2.7%N/A0.1 $0.25 12/15/20242,230,000 shares $532,524.00 -14.2%N/A0.1 $0.24 11/30/20242,600,000 shares $901,940.00 -31.6%N/A0.1 $0.35 11/15/20243,800,000 shares $1.58 million -32.6%N/A0.2 $0.42 10/31/20245,640,000 shares $2.29 million +208.2%N/A0.3 $0.41 10/15/20241,830,000 shares $278,892.00 +11.6%N/A1.6 $0.15 9/30/20241,640,000 shares $277,160.00 -9.9%N/A1.5 $0.17 9/15/20241,820,000 shares $309,400.00 -5.7%N/A0.5 $0.17 8/31/20241,930,000 shares $340,259.00 -16.5%N/A0.5 $0.18 8/15/20242,310,000 shares $413,952.00 -25.7%N/A0.6 $0.18 Get the Latest News and Ratings for GLYC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GlycoMimetics and its competitors with MarketBeat's FREE daily newsletter. 7/31/20243,110,000 shares $674,870.00 +9.1%N/A0.8 $0.22 7/15/20242,850,000 shares $883,500.00 -44.2%N/A0.7 $0.31 6/30/20245,110,000 shares $1.44 million +190.3%N/A1.2 $0.28 6/15/20241,760,000 shares $462,880.00 -15.8%N/A0.4 $0.26 5/31/20242,090,000 shares $566,390.00 -10.7%N/A1.2 $0.27 5/15/20242,340,000 shares $631,800.00 -61.6%N/A1.5 $0.27 4/30/20246,090,000 shares $10.96 million +102.3%N/A4.6 $1.80 4/15/20243,010,000 shares $6.79 million +89.3%N/A6.6 $2.26 3/31/20241,590,000 shares $4.77 million +6.7%N/A4.3 $3.00 3/15/20241,490,000 shares $3.81 million -4.5%N/A4.2 $2.56 2/29/20241,560,000 shares $4.51 million +9.1%N/A4.6 $2.89 2/15/20241,430,000 shares $4.42 million +43.3%N/A4.5 $3.09 1/31/2024997,900 shares $2.99 million +24.8%N/A3.5 $3.00 1/15/2024799,700 shares $2.49 million +40.3%N/A3.3 $3.11 12/31/2023570,000 shares $1.35 million -11.2%N/A2.9 $2.36 12/15/2023641,600 shares $1.27 million -23.7%N/A3.8 $1.98 11/30/2023841,200 shares $1.38 million -4.3%N/A7 $1.64 11/15/2023878,900 shares $1.22 million -1.6%N/A7.5 $1.39 10/31/2023893,500 shares $1.12 million -8.9%N/A7.3 $1.25 10/15/2023981,100 shares $1.39 million +4.3%N/A8.1 $1.42 9/30/2023940,300 shares $1.41 million -7.8%N/A8.2 $1.50 9/15/20231,020,000 shares $1.44 million -1.9%N/A8.8 $1.41 8/31/20231,040,000 shares $1.66 million -6.3%N/A7.6 $1.60 8/15/20231,110,000 shares $1.78 million -4.3%N/A6.6 $1.60 7/31/20231,160,000 shares $1.90 million -4.9%N/A5.1 $1.64 7/15/20231,220,000 shares $2.01 million -1.6%N/A5.2 $1.65 6/30/20231,240,000 shares $2.16 million +1.6%N/A5.1 $1.74 6/15/20231,220,000 shares $2.33 million -14.1%N/A4.3 $1.91 5/31/20231,420,000 shares $2.64 million +7.6%N/A4.5 $1.86 5/15/20231,320,000 shares $2.75 million -2.2%N/A2.8 $2.08$2 Trillion Disappears Because of Fed's Secretive New Move (Ad)$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.Click here to see his new research now. 4/30/20231,350,000 shares $1.89 million -13.5%N/A1.3 $1.40 4/15/20231,560,000 shares $2.29 million -23.5%N/A1.2 $1.47 3/31/20232,040,000 shares $2.57 million -0.5%N/A1.5 $1.26 3/15/20232,050,000 shares $3.05 million -23.5%4.5%1.4 $1.49 2/28/20232,680,000 shares $4.13 million +92.8%5.8%1.8 $1.54 2/15/20231,390,000 shares $2.11 million +40.0%3.0%1 $1.52 1/31/2023992,600 shares $2.89 million +50.2%2.2%1 $2.91 1/15/2023660,700 shares $2.00 million +7.8%1.6%1 $3.02 12/30/2022613,000 shares $1.86 million +20.8%1.5%1.1 $3.03 12/15/2022507,300 shares $1.03 million -0.6%1.2%1.2 $2.04 11/30/2022510,200 shares $1.10 million -14.2%1.2%1.4 $2.16 11/15/2022594,500 shares $1.01 million +3.6%1.4%1.9 $1.70 10/31/2022574,100 shares $389,412.03 +19.7%1.4%5.1 $0.68 10/15/2022479,700 shares $298,133.55 +2.4%1.1%3.9 $0.62 9/30/2022468,700 shares $258,581.79 -5.8%1.1%3.6 $0.55 9/15/2022497,300 shares $341,098.07 -1.8%1.2%3.7 $0.69 8/31/2022506,300 shares $384,788.00 +6.1%1.2%3.5 $0.76 8/15/2022477,300 shares $400,932.00 -10.9%1.1%3.5 $0.84 7/31/2022535,500 shares $355,036.50 -6.8%1.6%3.6 $0.66 7/15/2022574,500 shares $363,141.45 +4.3%1.7%3.4 $0.63 6/30/2022551,000 shares $329,442.90 -17.1%1.7%3.1 $0.60 6/15/2022664,400 shares $372,794.84 +2.3%2.0%3.7 $0.56 5/31/2022649,500 shares $432,437.10 +5.8%1.5%3.7 $0.67 5/15/2022613,700 shares $346,126.80 -2.3%1.5%3.1 $0.56 4/30/2022628,300 shares $451,496.38 +3.9%1.5%3 $0.72 4/15/2022605,000 shares $605,000.00 -1.1%1.4%3 $1.00 3/31/2022612,000 shares $697,680.00 -2.3%1.5%2.9 $1.14 3/15/2022626,400 shares $645,192.00 -8.9%1.5%2.6 $1.03 2/28/2022687,600 shares $845,748.00 +1.3%1.7%2.6 $1.23 2/15/2022678,600 shares $719,316.00 -10.1%1.6%2.4 $1.06 1/31/2022754,700 shares $898,093.00 +13.5%1.8%2.4 $1.19 1/15/2022665,200 shares $824,848.00 +1.2%N/A2 $1.24 12/31/2021657,600 shares $946,944.00 -2.7%1.6%1.9 $1.44 12/15/2021676,000 shares $1.03 million +1.8%1.6%1.1 $1.52 11/30/2021664,300 shares $1.12 million -10.2%1.6%1 $1.69 11/15/2021739,400 shares $1.58 million -0.5%1.8%1.1 $2.14 10/29/2021743,300 shares $1.42 million -12.7%1.8%1.2 $1.91 10/15/2021851,000 shares $1.68 million -21.9%2.1%1.3 $1.98 9/30/20211,090,000 shares $2.39 million +1.9%2.6%1.7 $2.19 9/15/20211,070,000 shares $2.29 million -2.7%2.6%2.1 $2.14 8/31/20211,100,000 shares $2.44 million -28.6%2.7%2.4 $2.22 8/13/20211,540,000 shares $3.05 million -6.7%3.7%3.2 $1.98 7/30/20211,650,000 shares $3.33 million No Change4.0%2.4 $2.02 7/15/20211,650,000 shares $3.35 million +7.1%4.0%2.3 $2.03 6/30/20211,540,000 shares $3.57 million -37.1%3.7%1.9 $2.32 6/15/20212,450,000 shares $6.32 million -11.6%5.9%3.2 $2.58 5/28/20212,770,000 shares $7.06 million +26.5%6.7%3.5 $2.55 5/14/20212,190,000 shares $5.52 million -11.0%5.3%2.4 $2.52 4/30/20212,460,000 shares $6.15 million +74.5%6.0%3 $2.50 4/15/20211,410,000 shares $3.71 million +6.8%3.4%1.6 $2.63$2 Trillion Disappears Because of Fed's Secretive New Move (Ad)$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.Click here to see his new research now. 3/31/20211,320,000 shares $3.83 million +3.9%3.2%1.5 $2.90 3/15/20211,270,000 shares $4.20 million +18.7%3.2%1.5 $3.31 2/26/20211,070,000 shares $3.66 million +16.4%2.7%1.3 $3.42 2/12/2021919,100 shares $3.74 million +4.6%2.5%1.2 $4.07 1/29/2021878,800 shares $3.22 million -2.9%2.3%1.2 $3.66 1/15/2021904,700 shares $3.40 million -54.3%2.4%1.3 $3.76 12/31/20201,980,000 shares $7.50 million -21.7%5.3%3.2 $3.79 12/15/20202,530,000 shares $9.21 million +36.0%6.7%4.3 $3.64 11/30/20201,860,000 shares $6.81 million -5.6%4.9%3.7 $3.66 11/15/20201,970,000 shares $6.88 million +1.0%5.2%4.7 $3.49 10/30/20201,950,000 shares $5.62 million -11.4%5.2%5.6 $2.88 10/15/20202,200,000 shares $7.55 million +8.9%5.8%7.4 $3.43 9/30/20202,020,000 shares $6.20 million -5.6%5.4%5.2 $3.07 9/15/20202,140,000 shares $7.62 million -0.5%5.7%4.2 $3.56 8/31/20202,150,000 shares $7.93 million -2.7%5.7%2.8 $3.69 8/14/20202,210,000 shares $8.18 million -3.5%6.0%2.8 $3.70 7/31/20202,290,000 shares $9.02 million -7.7%6.2%2.9 $3.94 7/15/20202,480,000 shares $9.94 million -11.1%7.4%3.3 $4.01 6/30/20202,790,000 shares $10.49 million +4.5%8.3%4.1 $3.76 6/15/20202,670,000 shares $8.09 million -0.4%8.0%4.8 $3.03 5/29/20202,680,000 shares $7.58 million -0.7%8.0%8 $2.83 5/15/20202,700,000 shares $8.40 million -3.2%8.1%8.5 $3.11 4/30/20202,790,000 shares $7.78 million -3.1%8.3%9.9 $2.79 4/15/20202,880,000 shares $7.43 million -6.8%8.6%11.2 $2.58 3/31/20203,090,000 shares $7.73 million -4.6%9.2%12.1 $2.50 3/13/20203,240,300 shares $8.62 million +0.9%9.7%15.9 $2.66 2/28/20203,210,000 shares $6.90 million +0.6%9.6%15.4 $2.15 2/14/20203,190,000 shares $9.89 million -4.8%9.6%14.4 $3.10 1/31/20203,350,000 shares $12.26 million +3.1%10.1%13.9 $3.66 GLYC Short Interest - Frequently Asked Questions What is GlycoMimetics' current short interest? Short interest is the volume of GlycoMimetics shares that have been sold short but have not yet been covered or closed out. As of December 31st, traders have sold 2,170,000 shares of GLYC short. Learn More on GlycoMimetics' current short interest. Which institutional investors are shorting GlycoMimetics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of GlycoMimetics: LMR Partners LLP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is GlycoMimetics' short interest increasing or decreasing? GlycoMimetics saw a decrease in short interest in the month of December. As of December 31st, there was short interest totaling 2,170,000 shares, a decrease of 2.7% from the previous total of 2,230,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does GlycoMimetics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to GlycoMimetics: BeyondSpring Inc. (5.82%), Mural Oncology plc (2.80%), Generation Bio Co. (4.14%), Immuneering Co. (7.86%), NRx Pharmaceuticals, Inc. (6.99%), Eliem Therapeutics, Inc. (2.22%), Werewolf Therapeutics, Inc. (5.22%), FibroGen, Inc. (3.03%), Connect Biopharma Holdings Limited (0.14%), Gain Therapeutics, Inc. (1.33%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short GlycoMimetics stock? Short selling GLYC is an investing strategy that aims to generate trading profit from GlycoMimetics as its price is falling. GLYC shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against GlycoMimetics? A short squeeze for GlycoMimetics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GLYC, which in turn drives the price of the stock up even further. How often is GlycoMimetics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GLYC, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies BeyondSpring Short Interest Mural Oncology Short Interest Generation Bio Short Interest Immuneering Short Interest NRx Pharmaceuticals Short Interest Eliem Therapeutics Short Interest Werewolf Therapeutics Short Interest FibroGen Short Interest Connect Biopharma Short Interest Gain Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GLYC) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlycoMimetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GlycoMimetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GLYC Stock Alerts